| ABT-267, ABT 333, ABT-450 and Ritonavir |
AbbVie |
June 2017 |
|
| Cemiplimab (REGN2810) |
Regeneron Pharmaceuticals, Inc. |
September 2021 |
|
| Cenicriviroc Mesylate CVC (TBR-652) |
Allergan |
April 2022 |
|
| Dapivirine (Vaginal Ring) |
International Partnership For Microbicides |
September 2021 |
|
| Delamanid (OPC-67683) - New - New |
Otsuka |
May 2023 |
|
| Dolutegravir (GSK1349572) |
ViiV Healthcare |
October 2022 |
|
| Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) |
Merck |
July 2021 |
|
| Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) |
Gilead Sciences |
December 2016 |
YES |
| Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) |
AbbVie |
December 2018 |
|
| GSK1265744 (Cabotegravir) |
ViiV Healthcare |
January 2023 |
|
| Letermovir - New - New |
Merck |
December 2022 |
|
| Pretomanid (PA-824) |
Global Alliance for TB Drug Development (TB Alliance) |
January 2023 |
|
| Remdesivir (Veklury) |
Gilead Sciences |
June 2021 |
|
| Rilpivirine (TMC278, Edurant) - New - New |
Janssen Research & Development |
July 2023 |
|
| Sofosbuvir/Velapatasvir (Epclusa) |
Gilead |
July 2016 |
|
| Tecovirimat (TPOXX) |
SIGA Technologies, Inc. |
December 2022 |
|
| Tenofovir Alafenamide/Elvitegravir |
CONRAD |
July 2019 |
|
| Vorinostat (Zolinza) |
Merck |
August 2013 |
|
